PharmaciesHospitalsDoctorsPatientsManufacturers
Masters Medical Inc (MMI) based in Florida is pleased to announce that it has become a member of the Healthcare Distribution Management Association (HDMA). This affliliation will provide additional resource to further strengthen the Masters supply chain and enhance the services we provide to our valued customers.
Masters, focused on providing the Patient, wherever they are, access to the best available treatments.
Masters Pharmaceuticals Ltd is pleased to announce the availability of sodium cromoglicate 100mg Tablets for the alleviation of the symptoms of Systemic Mastocytosis and Mast Cell Activation Syndrome.
Please see the information below regarding supply:
Masters Pharmaceuticals Limited in the United Kingdom is pleased to announce the availability of Lorazepam Injection 4mg/mL.
Presentation: Lorazepam Injection 4mg/mL is supplied as 1mL vials in packs of 25
Mastocytosis is a rare disease that occurs in both children and adults. It is characterized by the presence of too many mast cells in connective tissues such as the skin, the lining of the stomach, intestine and other sites. Mast cells play a critical role in the immune system’s response to defend the body against infection and disease.
Masters' knowledge and experience of emerging markets and different therapeutic sectors makes it an ideal partner for increasing global demand.
Our dedicated business development team and proven track record guarantees that Masters can offer a thorough, rapid and flexible approach to partnerships and commercialising products globally.
